RNAM
Avidity Biosciences Inc
NASDAQ · Healthcare · Biotechnology · US
$72.86
+0.05%Margins
Gross margin
77.9%
EBITDA margin
-3955.2%
EBIT margin
-3977.3%
Net margin
-3650.4%
FCF margin
-3539.1%
-40.5%
Return on equity
-35.0%
Return on assets
-41.8%
Return on invested capital
0.01x
Asset turnover
-$650.4M
Cash from operations
$12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025